Prioritise growth where market attractiveness meets your right-to-win.
The right opportunity sits at the intersection of external attractiveness, customer need, competitive intensity, strategic fit, capability readiness and economic potential.

What we analyse
- Opportunity universe creation
- Market and country screening
- Segment and application prioritisation
- Adjacency mapping
- Customer opportunity assessment
- Portfolio whitespace
- Build / partner / acquire / channel options
- Business-case support and implementation roadmap
Questions this work helps answer
- Which markets, countries, applications or customer segments deserve priority?
- Which adjacencies fit our capabilities?
- Where is unmet need?
- Which growth plays balance upside, feasibility and timing?
How we create decision value
We score external attractiveness alongside right-to-win so recommendations reflect execution barriers, customer access, regulation, channel economics and incumbent strength—not market growth alone.

Typical outputs
- Growth opportunity map
- Prioritisation scorecard
- Adjacency matrix
- Strategic options
- Entry pathways
- Action roadmap
- Executive recommendation
Delivered across our industries
Every engagement is staffed by analysts who have worked inside the sector they are covering.
Pharmaceuticals
Therapeutic areas, access, pricing and tender dynamics
View coverage →Medical Devices
Diagnostics, implants, imaging and connected care
View coverage →Petrochemicals
Feedstock economics, downstream margins and derivatives
View coverage →Oil & Gas
Upstream, midstream and the energy transition
View coverage →Prioritise your next growth move →
Tell us what you need to understand, decide or validate. We will use it to determine the right research approach and the level of depth required.
